Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. BURRIS HA; RAYMOND E; AWADA A; KUHN JG; OROURKE TJ; BRENTZEL J; LYNCH W; KING SYP; BROWN TD; VONHOFF DD
   PHARMACOKINETIC AND PHASE-I STUDIES OF BREQUINAR (DUP-785, NSC-368390) IN COMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED MALIGNANCIES
   Investigational new drugs
   
   H.A. Burris et al., "PHARMACOKINETIC AND PHASE-I STUDIES OF BREQUINAR (DUP-785, NSC-368390) IN COMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED MALIGNANCIES", Investigational new drugs, 16(1), 1998, pp. 19-27
2. RENLUND DG; GOPINATHAN SK; KFOURY AG; TAYLOR DO
   MYCOPHENOLATE MOFETIL (MMF) IN HEART-TRANSPLANTATION - REJECTION PREVENTION AND TREATMENT
   Clinical transplantation
   
   D.G. Renlund et al., "MYCOPHENOLATE MOFETIL (MMF) IN HEART-TRANSPLANTATION - REJECTION PREVENTION AND TREATMENT", Clinical transplantation, 10(1), 1996, pp. 136-139
3. VANLAAR JAM; RUSTUM YM; VANDERWILT C; SMID K; KUIPER CM; PINEDO HM; PETERS GJ
   TUMOR SIZE AND ORIGIN DETERMINE THE ANTITUMOR-ACTIVITY OF CISPLATIN OR 5-FLUOROURACIL AND ITS MODULATION BY LEUCOVORIN IN MURINE COLON CARCINOMAS
   Cancer chemotherapy and pharmacology
   
   J.A.M. Vanlaar et al., "TUMOR SIZE AND ORIGIN DETERMINE THE ANTITUMOR-ACTIVITY OF CISPLATIN OR 5-FLUOROURACIL AND ITS MODULATION BY LEUCOVORIN IN MURINE COLON CARCINOMAS", Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 79-89
4. CAO WW; KAO PN; CHAO AC; GARDNER P; NG J; MORRIS RE
   MECHANISM OF THE ANTIPROLIFERATIVE ACTION OF LEFLUNOMIDE - A77-1726, THE ACTIVE METABOLITE OF LEFLUNOMIDE, DOES NOT BLOCK T-CELL RECEPTOR-MEDIATED SIGNAL-TRANSDUCTION BUT ITS ANTIPROLIFERATIVE EFFECTS ARE ANTAGONIZED BY PYRIMIDINE NUCLEOSIDES
   The Journal of heart and lung transplantation
   
   W.W. Cao et al., "MECHANISM OF THE ANTIPROLIFERATIVE ACTION OF LEFLUNOMIDE - A77-1726, THE ACTIVE METABOLITE OF LEFLUNOMIDE, DOES NOT BLOCK T-CELL RECEPTOR-MEDIATED SIGNAL-TRANSDUCTION BUT ITS ANTIPROLIFERATIVE EFFECTS ARE ANTAGONIZED BY PYRIMIDINE NUCLEOSIDES", The Journal of heart and lung transplantation, 14(6), 1995, pp. 1016-1030
5. BUZAID AC; PIZZORNO G; MARSH JC; RAVIKUMAR TS; MURREN JR; TODD M; STRAIR RK; POO WJ; HAIT WN
   BIOCHEMICAL MODULATION OF 5-FLUOROURACIL WITH BREQUINAR - RESULTS OF A PHASE-I STUDY
   Cancer chemotherapy and pharmacology
   
   A.C. Buzaid et al., "BIOCHEMICAL MODULATION OF 5-FLUOROURACIL WITH BREQUINAR - RESULTS OF A PHASE-I STUDY", Cancer chemotherapy and pharmacology, 36(5), 1995, pp. 373-378
6. CODY R; STEWART D; DEFORNI M; MOORE M; DALLAIRE B; AZARNIA N; GYVES J
   MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED BREAST-CANCER
   American journal of clinical oncology
   
   R. Cody et al., "MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED BREAST-CANCER", American journal of clinical oncology, 16(6), 1993, pp. 526-528
7. MOORE M; MAROUN J; ROBERT F; NATALE R; NEIDHART J; DALLAIRE B; SISK R; GYVES J
   MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED GASTROINTESTINAL CANCER
   Investigational new drugs
   
   M. Moore et al., "MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED GASTROINTESTINAL CANCER", Investigational new drugs, 11(1), 1993, pp. 61-65
8. ALLISON AC; EUGUI EM
   INHIBITORS OF DENOVO PURINE AND PYRIMIDINE SYNTHESIS AS IMMUNOSUPPRESSIVE DRUGS
   Transplantation proceedings
   
   A.C. Allison e E.M. Eugui, "INHIBITORS OF DENOVO PURINE AND PYRIMIDINE SYNTHESIS AS IMMUNOSUPPRESSIVE DRUGS", Transplantation proceedings, 25(3), 1993, pp. 8-18
9. WOO J; LEMSTER B; TAMURA K; STARZL TE; THOMSON AW
   THE ANTILYMPHOCYTIC ACTIVITY OF BREQUINAR SODIUM AND ITS POTENTIATIONBY CYTIDINE - EFFECTS ON LYMPHOCYTE-PROLIFERATION AND CYTOKINE PRODUCTION
   Transplantation
   
   J. Woo et al., "THE ANTILYMPHOCYTIC ACTIVITY OF BREQUINAR SODIUM AND ITS POTENTIATIONBY CYTIDINE - EFFECTS ON LYMPHOCYTE-PROLIFERATION AND CYTOKINE PRODUCTION", Transplantation, 56(2), 1993, pp. 374-381
10. TAMURA K; WOO J; BAKRI MT; THOMSON AW
    BREQUINAR SODIUM INHIBITS INTERLEUKIN-6-INDUCED DIFFERENTIATION OF A HUMAN B-CELL LINE INTO IGM-SECRETING PLASMA-CELLS
    Immunology
    
    K. Tamura et al., "BREQUINAR SODIUM INHIBITS INTERLEUKIN-6-INDUCED DIFFERENTIATION OF A HUMAN B-CELL LINE INTO IGM-SECRETING PLASMA-CELLS", Immunology, 79(4), 1993, pp. 587-593